HOW SUPPLIED:
Loxapine Capsules, USP are available containing loxapine succinate, USP 13.6 mg, 34 mg or 68 mg equivalent to 10 mg, 25 mg or 50 mg of loxapine base, respectively.
The 10 mg capsules have a hard-shell gelatin capsule with an olive opaque cap and a yellow opaque body axially printed with MYLAN over 7010 in black ink on both the cap and body. The capsule is filled with white to off-white powder. They are available as follows:
NDC 51079-901-20 – Unit dose blister packages of 100 (10 cards of 10 capsules each).
The 25 mg capsules have a hard-shell gelatin capsule with an olive opaque cap and a light green opaque body axially printed with MYLAN over 7025 in black ink on both the cap and body. The capsule is filled with white to off-white powder. They are available as follows:
NDC 51079-902-20 – Unit dose blister packages of 100 (10 cards of 10 capsules each).
The 50 mg capsules have a hard-shell gelatin capsule with an olive opaque cap and a light blue opaque body axially printed with MYLAN over 7050 in black ink on both the cap and body. The capsule is filled with white to off-white powder. They are available as follows:
NDC 51079-903-20 – Unit dose blister packages of 100 (10 cards of 10 capsules each).
Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]
Manufactured by:
Mylan Pharmaceuticals Inc.
Morgantown, WV 26505 U.S.A.
Distributed by:
Mylan Institutional Inc.
Rockford, IL 61103 U.S.A.
S-8571 R6 12/12
|